Correlation Between X4 Pharmaceuticals and Lexicon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Lexicon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Lexicon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Lexicon Pharmaceuticals, you can compare the effects of market volatilities on X4 Pharmaceuticals and Lexicon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Lexicon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Lexicon Pharmaceuticals.
Diversification Opportunities for X4 Pharmaceuticals and Lexicon Pharmaceuticals
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between XFOR and Lexicon is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Lexicon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexicon Pharmaceuticals and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Lexicon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexicon Pharmaceuticals has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Lexicon Pharmaceuticals go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Lexicon Pharmaceuticals
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.39 times more return on investment than Lexicon Pharmaceuticals. However, X4 Pharmaceuticals is 1.39 times more volatile than Lexicon Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Lexicon Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 92.00 in X4 Pharmaceuticals on November 2, 2024 and sell it today you would lose (21.99) from holding X4 Pharmaceuticals or give up 23.9% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
X4 Pharmaceuticals vs. Lexicon Pharmaceuticals
Performance |
Timeline |
X4 Pharmaceuticals |
Lexicon Pharmaceuticals |
X4 Pharmaceuticals and Lexicon Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with X4 Pharmaceuticals and Lexicon Pharmaceuticals
The main advantage of trading using opposite X4 Pharmaceuticals and Lexicon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Lexicon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexicon Pharmaceuticals will offset losses from the drop in Lexicon Pharmaceuticals' long position.X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Lexicon Pharmaceuticals vs. BioLineRx | Lexicon Pharmaceuticals vs. Ardelyx | Lexicon Pharmaceuticals vs. Seres Therapeutics | Lexicon Pharmaceuticals vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |